These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
134 related items for PubMed ID: 1111918
1. Immunologic evaluation of human bladder cancer: in vitro studies. Elhilali MM, Nayak SK. Cancer; 1975 Feb; 35(2):419-31. PubMed ID: 1111918 [Abstract] [Full Text] [Related]
3. Cellular cytotoxicity in vitro in transitional cell carcinoma of the human urinary bladder: 51Cr-release assay. Troye M, Perlmann P, Larsson A, Blomgren H, Johansson B. Int J Cancer; 1977 Aug 15; 20(2):188-98. PubMed ID: 892930 [No Abstract] [Full Text] [Related]
6. Characterization of cytolytic effector cells in peripheral blood of healthy individuals and cancer patients. II. Cytotoxicity to allogeneic or autochthonous tumor cells in tissue culture. Pape GR, Troye M, Perlmann P. J Immunol; 1977 Jun 15; 118(6):1925-30. PubMed ID: 325130 [No Abstract] [Full Text] [Related]
7. Cellular cytotoxicity in transitional cell carcinoma of the human urinary bladder - a summary. Perlmann P, Troye M, Pape G, Blomgren H, Johansson B. Urol Res; 1978 Jun 15; 6(4):207-9. PubMed ID: 741533 [Abstract] [Full Text] [Related]
8. Cell-mediated cytotoxicity against human bladder cancer. Bloom ET, Ossorio RC, Brosman SA. Int J Cancer; 1974 Sep 15; 14(3):326-34. PubMed ID: 4477556 [No Abstract] [Full Text] [Related]
9. Cell-mediated tumour immunity in patients with transitional cell carcinoma of the urinary bladder. Bubeník J. Int Urol Nephrol; 1975 Sep 15; 7(4):297-302. PubMed ID: 1107249 [Abstract] [Full Text] [Related]
10. Lymphoid cells mediating tumor-specific cytotoxicity to carcinoma of the urinary bladder. Separation of the effector population using a surface marker. O'Toole C, Stejskal V, Perlmann P, Karlsson M. J Exp Med; 1974 Mar 01; 139(3):457-66. PubMed ID: 4591169 [Abstract] [Full Text] [Related]
11. Evaluation of immunological reactivity in bladder cancer. O'Boyle PJ, Cooper EH, Williams RE. Br J Urol; 1974 Jun 01; 46(3):303-8. PubMed ID: 4843725 [No Abstract] [Full Text] [Related]
12. Lymphocyte antibody interaction in cytotoxicity against human transitional cell carcinoma. Hakala TR, Lange PH, Castro AE, Elliott AY, Fraley EE. J Urol; 1975 May 01; 113(5):663-7. PubMed ID: 1168732 [Abstract] [Full Text] [Related]
13. Lymphocyte cytotoxicity against autologous bladder tumor cells in humans, investigated by use of a chromium-51 release assay. Jacobsen F. Acta Pathol Microbiol Scand C; 1981 Jun 01; 89(3):175-80. PubMed ID: 7315355 [Abstract] [Full Text] [Related]
14. Specificity of in vitro cellular cytotoxicity against transitional cell carcinoma cell line T-24. Catalona WJ, Oldham RK, Djeu JY, Herberman RB, Cannon GB. Surg Forum; 1975 Jun 01; 26():122-4. PubMed ID: 56048 [No Abstract] [Full Text] [Related]
15. Cytotoxicity in vitro of blood lymphocytes from bladder cancer patients and controls to allogeneic or autologous tumor cells derived from established cell lines or short-term cultures. Troye M, Vilien M, Pape GR, Perlmann P. Int J Cancer; 1980 Jan 15; 25(1):33-43. PubMed ID: 7399743 [Abstract] [Full Text] [Related]